Published in Nucleosides Nucleotides Nucleic Acids on September 20, 2001
Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA. Nucleic Acids Res (2003) 0.94
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci U S A (1989) 1.97
Complementary-addressed (sequence-specific) modification of nucleic acids. Prog Nucleic Acid Res Mol Biol (1985) 1.87
Fluorescence energy transfer as a probe for nucleic acid structures and sequences. Nucleic Acids Res (1994) 1.83
Health care, medical practice, and medical ethics in Russia today. JAMA (1995) 1.76
Tertiary structure of tRNAs in solution monitored by phosphodiester modification with ethylnitrosourea. Eur J Biochem (1981) 1.56
The conformations of locked nucleic acids (LNA). J Mol Recognit (2000) 1.41
Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells. FEBS Lett (1989) 1.35
Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry (2002) 1.35
Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer (2006) 1.32
The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2'-thio-LNA. Bioorg Med Chem Lett (1998) 1.24
Interaction of tRNAPhe and tRNAVal with aminoacyl-tRNA synthetases. A chemical modification study. Eur J Biochem (1983) 1.13
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv Enzyme Regul (1985) 1.06
Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res (1999) 0.98
Complementary addressed modification and cleavage of a single stranded DNA fragment with alkylating oligonucleotide derivatives. Nucleic Acids Res (1986) 0.98
RNase T1 mimicking artificial ribonuclease. Nucleic Acids Res (2007) 0.95
Site-specific cleavage of single-stranded DNAs at unique sites by a copper-dependent redox reaction. Nature (1988) 0.95
Synthetic RNA-cleaving molecules mimicking ribonuclease A active center. Design and cleavage of tRNA transcripts. Nucleic Acids Res (1993) 0.91
Sequence-specific chemical modification of a 365-nucleotide-long DNA fragment with an alkylating oligonucleotide derivative. FEBS Lett (1985) 0.90
Structural arrangement of tRNA binding sites on Escherichia coli ribosomes, as revealed from data on affinity labelling with photoactivatable tRNA derivatives. Biochim Biophys Acta (1989) 0.89
Porphyrin-linked oligonucleotides. Synthesis and sequence-specific modification of ssDNA. FEBS Lett (1990) 0.89
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects. Adv Enzyme Regul (1985) 0.86
Chemical and computer probing of RNA structure. Prog Nucleic Acid Res Mol Biol (1996) 0.86
The tertiary structure of yeast tRNAPhe in solution studied by phosphodiester bond modification with ethylnitrosourea. FEBS Lett (1980) 0.86
Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids. Biochimie (1986) 0.86
Protection of phosphodiester bonds in yeast tRNAVal by its cognate aminoacyl-tRNA synthetase against alkylation by ethylnitrosourea. FEBS Lett (1981) 0.86
Antisense oligonucleotide derivatives as gene-targeted drugs. Biomed Sci (1990) 0.85
Hybridization of antisense oligonucleotides with the 3'part of tRNA(Phe). FEBS Lett (1999) 0.85
Secondary structure of the 5'-region of PGY1/MDR1 mRNA. FEBS Lett (2000) 0.85
Cleavage of RNA with synthetic ribonuclease mimics. Methods Enzymol (2000) 0.85
Cleavage of RNA by an amphiphilic compound lacking traditional catalytic groups. Bioorg Chem (2007) 0.84
Nucleic acids in exosomes: disease markers and intercellular communication molecules. Biochemistry (Mosc) (2013) 0.84
[Sensitized photomodification by binary systems. I. Synthesis of oligonucleotide reagents, and the effect of their structure on the efficacy of target modification]. Bioorg Khim (1997) 0.84
Cell membranes as barriers for antisense constructions. Antisense Res Dev (1992) 0.83
Cleavage of yeast tRNAPhe with complementary oligonucleotide conjugated to a small ribonuclease mimic. FEBS Lett (2000) 0.83
Extracellular DNA in culture of primary and transformed cells, infected and not infected with mycoplasma. Bull Exp Biol Med (2009) 0.81
Silencing of MDR 1 gene in cancer cells by siRNA. Nucleosides Nucleotides Nucleic Acids (2004) 0.81
Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probes. Genetica (1991) 0.80
Alkylation of tRNATrp in a complex with tryptophanyl-tRNA synthetase. FEBS Lett (1978) 0.80
Evaluation of oligonucleotides containing two novel 2'-O-methyl modified nucleotide monomers: a 3'-C-allyl and a 2'-O,3'-C-linked bicyclic derivative. Nucleosides Nucleotides (1999) 0.80
Deoxyribonuclease activity in biological fluids of healthy donors and cancer patients. Bull Exp Biol Med (2008) 0.80
Site-specific laser modification (cleavage) of oligodeoxynucleotides. Biopolymers (1989) 0.80
c-fos gene expression in cell revertants from a transformed to a pseudonormal phenotype. FEBS Lett (1993) 0.79
Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie (1993) 0.79
Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement. Nucleosides Nucleotides Nucleic Acids (2004) 0.79
Interaction of oligonucleotides with barrier fluid proteins. Biochemistry (Mosc) (1997) 0.79
Antiproliferative and interferon-inducing activities of unique short double-stranded RNA. Dokl Biochem Biophys (2011) 0.78
A Comparison of Target Gene Silencing using Synthetically Modified siRNA and shRNA That Express Recombinant Lentiviral Vectors. Acta Naturae (2009) 0.78
Rapid sequence-independent cellular response to oligodeoxynucleotides. FEBS Lett (1997) 0.78
Ribonuclease activity of the peptides with alternating arginine and leucine residues conjugated to tetrathymidilate. Nucleosides Nucleotides Nucleic Acids (2004) 0.78
Serum immunoglobulins interact with oligonucleotides. FEBS Lett (1994) 0.77
Structural studies by high-field NMR spectroscopy of a binary-addressed complementary oligonucleotide system juxtaposing pyrene and perfluoro-azide units. J Biomol Struct Dyn (1997) 0.77
Respiratory burst inhibition in human neutrophils by ultra-low doses of [D-Ala2]methionine enkephalinamide. FEBS Lett (1991) 0.77
Evidence from chemical modification for an unusual tertiary structure of the TpseudouridineC loop in rabbit liver tRNA1Val. FEBS Lett (1978) 0.77
Sequence-specific cleavage of single-stranded DNA by oligonucleotides conjugated to bleomycin. Antisense Res Dev (1992) 0.77
Structure of photoreactive binary system of oligonucleotide conjugates assembled on the target nucleotide sequence. J Biomol Struct Dyn (1999) 0.77
Involvement of the D-stem of tRNAPhe (E. coli) in interaction with phenylalanyl-tRNA synthetase as shown by chemical modification. FEBS Lett (1975) 0.77
Nuclear peptides specifically interacting with oligonucleotides. Nucleic Acids Symp Ser (1991) 0.77
[Directed chemical modification of DNA fragments by perfluorarylazide derivatives of oligonucleotides in the presence of oligonucleotides bearing photosensitized pyrene groups]. Dokl Akad Nauk (1995) 0.77
Tumoricidal Activity of RNase A and DNase I. Acta Naturae (2010) 0.76
The role of adhesive interactions and extracellular matrix fibronectin from human polymorphonuclear leukocytes in the respiratory burst. Biochim Biophys Acta (1991) 0.76
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. Acta Naturae (2009) 0.75
Cancer incidence in USAF aircrew. Aviat Space Environ Med (1999) 0.75
Silencing of c-myc expression in tumor cells by siRNA. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
Endogenous oligonucleotides of human milk and their possible biological function. Biochemistry (Mosc) (1999) 0.75
Activation of spleen lymphocytes by plasmid DNA. Vaccine (1999) 0.75
Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides. Virus Genes (1995) 0.75
Equilibrium screening-dialysis investigation of the nucleotide sequences in the tRNAPhe recognized by phenylalanyl-tRNA synthetase (Escherichia coli). FEBS Lett (1978) 0.75
Oligo(A), oligo(TG), and Alu repeats of DNA in chromatin are available for sequence-specific chemical modification with oligodeoxynucleotide derivatives. Antisense Res Dev (1994) 0.75
Sensitized photomodification of single-stranded DNA by a binary system of oligonucleotide conjugates. Antisense Nucleic Acid Drug Dev (1997) 0.75
Interaction of cholesterol-conjugated alkylating oligonucleotide derivatives with cellular biopolymers. FEBS Lett (1992) 0.75
Interaction of modified oligonucleotides with eukaryotic and mycoplasma cells and their fate inside the cells. Nucleic Acids Symp Ser (1991) 0.75
Oxidative DNA cleavage by free and oligonucleotide-conjugated O-bromobenzoic acid in the presence of copper(II) ions. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro. Eur J Biochem (1996) 0.75
The extracellular domain of CD4 receptor possesses a protein kinase activity. FEBS Lett (1998) 0.75
[Sequence-specific interaction of pyrimidine oligonucleotides with double-stranded DNA at acidic pH complexes of different types]. Bioorg Khim (2009) 0.75
Perfluoroarylazide derivatives of 2'-O-modified oligoribonucleotides: efficient reagents for RNA photomodification. Nucleosides Nucleotides Nucleic Acids (2005) 0.75
Suppression of influenza virus biopolymers functions and reproduction of the virus by oligodeoxynucleotide derivatives. Nucleic Acids Symp Ser (1991) 0.75
Complementary addressed modification of nucleic acids with the alkylating derivatives of oligothymidylate ethyl phosphotriesters. Effect of the phosphotriester fragments' configuration. FEBS Lett (1988) 0.75
Synthesis and transfection activity of novel galactosylated polycationic lipid. Bioorg Med Chem Lett (2011) 0.75
Structural and dynamic aspects of recognition between tRNAs and aminoacyl-tRNA synthetases. Mol Biol Biochem Biophys (1980) 0.75
Cell surface oligonucleotide-binding proteins of human squamous carcinoma A431 cells. Nucleosides Nucleotides Nucleic Acids (2003) 0.75
C-fos gene expression in spontaneously transformed mouse fibroblast cell lines. Nucleic Acids Symp Ser (1991) 0.75
[Photoactive ethidium and azidoethidium dyes. Synthesis, properties, and covalent bonding to oligodeoxynucleotides]. Bioorg Khim (1993) 0.75
Codon--anticodon interaction in Escherichia coli tRNAPhe. Chemical modification study. FEBS Lett (1980) 0.75
New porphyrin-linked oligonucleotide derivatives for sequence-specific chemical modification of DNA. Nucleic Acids Symp Ser (1991) 0.75
Sequence-specific alkylation of dsDNA with derivatives of pyrimidine oligonucleotides conjugated to 2-chloroethylamine groups. Antisense Res Dev (1991) 0.75
Affinity modification of human chromatin with reactive derivatives of oligonucleotides. FEBS Lett (1992) 0.75
Formation of nucleosomes does not suppress interaction of a DNA fragment with an alkylating derivative of a pyrimidine oligonucleotide. Antisense Nucleic Acid Drug Dev (1999) 0.75
Affinity modification of chromatin proteins located near open oligo(dA), oligo(dTG) and Alu-DNA sequences. Nucleic Acids Symp Ser (1991) 0.75
Cu(2+)-dependent DNA-cleaving activity of arenes. Nucleosides Nucleotides Nucleic Acids (2001) 0.75
Glyceraldehyde-3-phosphate dehydrogenase is responsible for intranuclear localization of some oligonucleotides. Nucleosides Nucleotides Nucleic Acids (2001) 0.75
New reagent for protein-DNA contacts footprinting. Nucleosides Nucleotides Nucleic Acids (2003) 0.75
Polio in Russia. Science (1994) 0.75
Specificity of interaction of pyrimidine oligonucleotides with DNA at acidic pH in the presence of magnesium ions: affinity modification study. Antisense Res Dev (1993) 0.75
Interaction of keratin K1 with nucleic acids on the cell surface. Biochemistry (Mosc) (2003) 0.75
Ethidium and azidoethidium oligonucleotide derivatives: synthesis, complementary complex formation and sequence-specific photomodification of the single-stranded and double-stranded target oligo- and polynucleotides. J Mol Recognit (1994) 0.75
Refined high-field NMR solution structure of a binary-addressed pyrene/perfluoro-azide complementary DNA oligonucleotide system shows extensive distortion in the central nick region. J Biomol Struct Dyn (1999) 0.75
DNA in chromatin is available for sequence-specific chemical modification with oligonucleotide derivatives. Nucleic Acids Symp Ser (1991) 0.75
Sequence specific chemical modification of single- and double-stranded DNA fragments with reactive oligonucleotide derivatives. Nucleic Acids Symp Ser (1991) 0.75